Real-time Continuous Glucose Monitoring (rt-cgm) Vs. Self-monitoring of Blood Glucose (smbg) in Type 1 Diabetes Patients (pwt1d) on Multiple Daily Injections ( Mdi): Latvian Cost-effectiveness Analysis

Hamza Alshannaq; Sabrina Ilham; Diaga Behmane; Greg Norman

Real-time Continuous Glucose Monitoring (rt-cgm) Vs. Self-monitoring of Blood Glucose (smbg) in Type 1 Diabetes Patients (pwt1d) on Multiple Daily Injections ( Mdi): Latvian Cost-effectiveness Analysis

Hamza Alshannaq
, Sabrina Ilham
, Diaga Behmane
, Greg Norman

Institute of Public Health

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	EV188
Pages (from-to)	A213-A214
Journal	Diabetes Technology & Therapeutics
Volume	26
Issue number	Suppl.1
Publication status	Published - 1 Feb 2024
Event	Advanced Techologies & Treatments for Diabetes CONFERENCE - Florence & Online, Italy Duration: 6 Mar 2024 → 9 Mar 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Field of Science*

3.3 Health sciences

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

https://www.liebertpub.com/doi/10.1089/dia.2024.2525.abstracts

Cite this

Alshannaq, H., Ilham, S., Behmane, D., & Norman, G. (2024). Real-time Continuous Glucose Monitoring (rt-cgm) Vs. Self-monitoring of Blood Glucose (smbg) in Type 1 Diabetes Patients (pwt1d) on Multiple Daily Injections ( Mdi): Latvian Cost-effectiveness Analysis. Diabetes Technology & Therapeutics, 26(Suppl.1), A213-A214. Article EV188 . https://www.liebertpub.com/doi/10.1089/dia.2024.2525.abstracts

@article{ae5b4070cae24aa8b56f4e6ae79931da,

title = "Real-time Continuous Glucose Monitoring (rt-cgm) Vs. Self-monitoring of Blood Glucose (smbg) in Type 1 Diabetes Patients (pwt1d) on Multiple Daily Injections ( Mdi): Latvian Cost-effectiveness Analysis",

author = "Hamza Alshannaq and Sabrina Ilham and Diaga Behmane and Greg Norman",

year = "2024",

month = feb,

day = "1",

language = "English",

volume = "26",

pages = "A213--A214",

journal = "Diabetes Technology \& Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "Suppl.1",

note = "Advanced Techologies \& Treatments for Diabetes CONFERENCE ; Conference date: 06-03-2024 Through 09-03-2024",

}

Alshannaq, H, Ilham, S, Behmane, D & Norman, G 2024, 'Real-time Continuous Glucose Monitoring (rt-cgm) Vs. Self-monitoring of Blood Glucose (smbg) in Type 1 Diabetes Patients (pwt1d) on Multiple Daily Injections ( Mdi): Latvian Cost-effectiveness Analysis', Diabetes Technology & Therapeutics, vol. 26, no. Suppl.1, EV188 , pp. A213-A214. <https://www.liebertpub.com/doi/10.1089/dia.2024.2525.abstracts>

Real-time Continuous Glucose Monitoring (rt-cgm) Vs. Self-monitoring of Blood Glucose (smbg) in Type 1 Diabetes Patients (pwt1d) on Multiple Daily Injections ( Mdi): Latvian Cost-effectiveness Analysis. / Alshannaq, Hamza; Ilham, Sabrina; Behmane, Diaga et al.
In: Diabetes Technology & Therapeutics, Vol. 26, No. Suppl.1, EV188 , 01.02.2024, p. A213-A214.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Real-time Continuous Glucose Monitoring (rt-cgm) Vs. Self-monitoring of Blood Glucose (smbg) in Type 1 Diabetes Patients (pwt1d) on Multiple Daily Injections ( Mdi)

T2 - Advanced Techologies & Treatments for Diabetes CONFERENCE

AU - Alshannaq, Hamza

AU - Ilham, Sabrina

AU - Behmane, Diaga

AU - Norman, Greg

PY - 2024/2/1

Y1 - 2024/2/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:001446043002050&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 1520-9156

VL - 26

SP - A213-A214

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

IS - Suppl.1

M1 - EV188

Y2 - 6 March 2024 through 9 March 2024

ER -

Real-time Continuous Glucose Monitoring (rt-cgm) Vs. Self-monitoring of Blood Glucose (smbg) in Type 1 Diabetes Patients (pwt1d) on Multiple Daily Injections ( Mdi): Latvian Cost-effectiveness Analysis

UN SDGs

Field of Science*

Publication Type*

Access to Document

Other files and links

Cite this